NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
и још 2

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Roswell Park Cancer Institute, Buffalo
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
и још 3

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Weill Cornell Medicine, Cornell University (site 126), New York

Тражи се учесникФаза 1/2

Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Maimonides Cancer Center, Brooklyn
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
и још 3

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
и још 4

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07638371

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START New York-Long Island, Lake Success
Memorial Sloan Kettering Cancer Center (MSKCC), New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07262619

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Roswell Park Cancer Institute, Buffalo
Icahan School of Medicine at Mount Sinai, New York
University of Rochester Medical Center, Rochester

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Roswell Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07094204

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Montefiore Medical Center-Einstein Campus, The Bronx
Montefiore Medical Center-Weiler Hospital, The Bronx
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05803382

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06127407

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, New York
Research Site, New York
Research Site, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

University of Rochester, Rochester

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Hematology Oncology Associates of Central New York, East Syracuse
Northwell Health Cancer Institute, Lake Success
Memorial Sloan-Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Тражи се учесникОпсервациона студија

2 Months · Оба пола · Ажурирано 22. 10. 2026. · NCT02474160

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07339176

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

START New York Long Island, LLC, New Hyde Park
NYU Langone Health, New York
Columbia University Irving Medical Center, New York
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06311214

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06521554

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
Columbia University, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT04977453

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, New York

Тражи се учесникФаза 1/2

Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT07038343

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Icahn School of Medicine at Mount Sinai, New York
University of Rochester Medical Center, Rochester

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Columbia University Irving Medical Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06915753

A Study of ASP3082 in Adults With Advanced Solid Tumors

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York
University of Rochester Medical Center James P. Wilmot Cancer Center, Rochester

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05382559

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York
Clinical Research Alliance, Inc., Westbury

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06757634

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Memorial Sloan Kettering Cancer Center ( Site 0006), New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06863272

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

New York Oncology Hematology, P.C., Albany
New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
MSK Commack, Commack
и још 7

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227415

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.